GRAIL, LLC (GRAL NASDAQ) stock market data APIs
$82.7506
-3.05(-3.7%)
as of October 23, 2025
Try our APIs with
free plan!
GRAIL, LLC Financial Data Overview
Price chart is built with
Anychart
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prev. Close
82.7506
Open
79.6988
High
83.467
Low
78.6535
52 wk Range
12.76-103
Market Cap
2 875 M
Shares Outstanding
36 048 K
Revenue
134 M
EPS
-3.18
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 134 M
- EBITDA: -407 344 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -3.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
GRAIL, Inc. (GRAL): A Bull Case Theory
We came across a bullish thesis on GRAIL, Inc. on Value investing subreddit by BombasticBillionaire. In this article, we will summarize the bulls’ thesis on GRAL. GRAIL, Inc.'s share was t...
Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 231% In A Month
Guardant Health stock broke out of a cup base as enthusiasm builds for the company's new blood test, Shield MCD. Continue Reading View Comments
GRAIL announces equity offering of $325.0M
* GRAIL (NASDAQ:GRAL [https://seekingalpha.com/symbol/GRAL]) has entered into a securities purchase agreement to raise $325M. * Pursuant to the terms of the securities purchase agreement, GRAIL ha...
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered int...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
